Astrazeneca reported 2.2B in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
AstraZeneca AZN:LN 181.11B 36.36B
Astrazeneca AZN:US 2.2B 673M
Bristol Myers Squibb BMY:US $ 3197M 9M
Canopy Growth Corp WEED:CN -114437000 194.91M
Catalent CTLT:US $ 261M 45M
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Eli Lilly And LLY:US $ 1650.5M 919.4M
Genmab GEN:DC 1.25B 733M
GlaxoSmithKline GSK:LN 181.6B 5.9B
Horizon Pharma HZNP:US 147M 49.44M
JAZZ PHA JAZZ:US 126.35M 38.8M
Johnson & Johnson JNJ:US $ 6941M 599M
Lannett LCI:US $ -23942000 3.64M
Merk MRK:US $ 5711M 652M
Novartis NOVN:VX 3.32B 176M
Pacira Pharmaceuticals PCRX:US $ 13.18M 8.55M
Perrigo Ordinary Shares PRGO:US $ 2.6M 20.5M
Pfizer PFE:US $ 12099M 2104M
Prestige Brands PBH:US $ 87.01M 9.59M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Teva Pharmaceutical Industries TEVA:US 734M 55M
Valeant Pharmaceuticals VRX:CN C$ 368.14M 60.14M
Zoetis ZTS:US $ 737M 57M